4/A: Vaccinex SVP Corrects Stock Option Transaction Details in Amended SEC Filing
SEC Filing (Form 4/A)
Ernest S. Smith, SVP of Research & CSO at Vaccinex, Inc., files an amended Form 4 to correct the transaction date and exercise price of a stock option grant.
Summary
- Ernest S. Smith, SVP, Research & CSO of Vaccinex, Inc., filed an amended Form 4 with the SEC.
- The amendment corrects the transaction date of a stock option grant from March 20, 2024, to March 21, 2024.
- The exercise price of the stock option is corrected to $8.21 per share, from the previously reported $8.32.
- The stock option grant of 1,341 shares was made under the company's 2018 Omnibus Incentive Plan and vests one-fourth on each of the first four anniversaries of the grant date.
Sentiment
Score: 7
Explanation: The document is a routine correction of a previous filing, indicating standard corporate governance practices. It doesn't inherently suggest positive or negative sentiment, but accuracy in reporting is generally viewed favorably.
Industry Context
Form 4 filings are standard practice for company insiders reporting transactions in their company's securities, ensuring transparency and compliance with SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 03/21/2024 | Corrected transaction date for stock option grant. |
| 03/21/2024 | Grant date of the stock option under the 2018 Omnibus Incentive Plan. |
| 03/22/2024 | Date of original Form 4 filing that contained the error. |
| 03/21/2034 | Expiration date of the stock option. |
| 05/14/2024 | Date of the amended Form 4 filing. |
Keywords
Vaccinex, VCNX, SEC Form 4, Stock Option, Amendment, Beneficial Ownership, Ernest S. Smith
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.